Solara Active Pharma reports ₹10 crore loss in Q2
after close1 source ↓written by the desknot a recommendation
- Revenue fell
- ₹3,140 million
Solara Active Pharma Sciences reported a loss of ₹10 crore for Q2 FY26, driven by operational disruptions at its Mangalore facility. Revenue fell to ₹3,140 million, down 10% year-on-year, due to delayed deliveries and reduced sales volumes. This performance may impact short-term investor sentiment in the pharmaceutical sector.
• Revenue decreased from ₹3,472 million in Q2 FY25
• Q1 FY26 revenue was ₹3,201 million
• Operational challenges stem from facility upgradation
Traders should monitor recovery signs as long-term fundamentals remain strong.
Not investment advice. For informational purposes only.